XML 40 R24.htm IDEA: XBRL DOCUMENT v3.3.1.900
Quarterly Financial Data (Notes)
 12 Months Ended
Dec. 31, 2015
Quarterly Financial Information Disclosure [Abstract]  
Quarterly Financial Information [Text Block]
Quarterly Financial Data (unaudited)

The tables below summarize the Company's unaudited quarterly operating results for the years ended December 31, 2015 and 2014, respectively.

 
Three Months Ended
(in thousands, except per share data)
March 31, 2015
 
June 30, 2015
 
September 30, 2015
 
December 31, 2015
Revenues
$
3,172

 
$
5,867

 
$
5,888

 
$
7,560

Total operating costs and expenses
$
21,260

 
$
31,536

 
$
16,271

 
$
67,269

Net loss
$
(19,231
)
 
$
(17,158
)
 
$
(11,393
)
 
$
(33,228
)
Net loss attributable to Caladrius Biosciences, Inc. common stockholders
$
(19,187
)
 
$
(17,126
)
 
$
(11,376
)
 
$
(33,197
)
Basic and diluted loss per share attributable to Caladrius Biosciences, Inc. common stockholders
$
(0.51
)
 
$
(0.38
)
 
$
(0.21
)
 
$
(0.59
)


 
Three Months Ended
(in thousands, except per share data)
March 31, 2014
 
June 30, 2014
 
September 30, 2014
 
December 31, 2014
Revenues
$
4,056

 
$
4,489

 
$
4,118

 
$
5,276

Total operating costs and expenses
$
17,555

 
$
16,919

 
$
20,376

 
$
20,830

Net loss
$
(13,830
)
 
$
(12,769
)
 
$
(17,177
)
 
$
(11,691
)
Net loss attributable to Caladrius Biosciences, Inc. common stockholders
$
(13,682
)
 
$
(12,605
)
 
$
(16,974
)
 
$
(11,612
)
Basic and diluted loss per share attributable to Caladrius Biosciences, Inc. common stockholders
$
(0.49
)
 
$
(0.40
)
 
$
(0.48
)
 
$
(0.32
)